Transcript levels of ANXA1, IGF2R, ITGB1, PDCD6IP and ACTR3 were significantly higher in GBM specimens, compared with normal brain across all three datasets (Fig. 4a–e). This evidence concerns the gene PDCD6IP and glioblastoma.